The Joint Genome Institute plans to transition from a sequencing center to a "genomic foundry" — a one-stop shop for large-scale functional annotation, single-cell genomics and transcriptomics, high-throughput custom sample prep, and analysis expertise, among other proposed services, said Eddy Rubin at JGI's sixth annual User Meeting in Walnut Creek, Calif.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.

Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.

The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.

In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.